Skip to main content

Table 1 Patient characteristics

From: Distance saturation product predicts health–related quality of life among sarcoidosis patients

Age (Mean ± SD) 45.9 ± 11.1 Disease, N (%)  
BMI (Mean ± SD) 32 ± 8.2  Inactive 45 (28)
Gender, N (%)    Active/Symptomatic† 117 (72)
 Male 45 (28) Organ Involvements N (%)  
 Female 117 (72) Lung 152 (94)
Race, N (%)   Skin 49 (30)
 African American 139 (86.8) Eye 43 (26)
 White 21(13.2) Heart 11 (6)
CXR stage, N (%)   Liver 18 (11)
0 13 (8.2) CNS 13 (6)
1 28 (17.7) PH* 28 (17)
2 65 (41.5) Medication, N (%)  
3 24 (14)  Steroidal 94 (58)
4 29(18.2)  IMD‡ 68 (42)
Non-smokers 123 (76)  Steroidal + IMD 77 (47)
  1. Values are means unless otherwise noted. N = number of patients, parenthesis = percent.
  2. *PH: pulmonary hypertension, diagnosed by right cardiac catheterization.
  3. † Active defined as an increased requirement for steroid in last 6 months.
  4. ‡ Immune modifying drugs like methotrexate, azathioprine and others.